These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12646611)

  • 1. Presentation by recycling MHC class II molecules of an influenza hemagglutinin-derived epitope that is revealed in the early endosome by acidification.
    Sinnathamby G; Eisenlohr LC
    J Immunol; 2003 Apr; 170(7):3504-13. PubMed ID: 12646611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential requirements for endosomal reduction in the presentation of two H2-E(d)-restricted epitopes from influenza hemagglutinin.
    Sinnathamby G; Maric M; Cresswell P; Eisenlohr LC
    J Immunol; 2004 Jun; 172(11):6607-14. PubMed ID: 15153475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocytic recycling is required for the presentation of an exogenous peptide via MHC class II molecules.
    Pathak SS; Blum JS
    Traffic; 2000 Jul; 1(7):561-9. PubMed ID: 11208144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophages present pinocytosed exogenous antigen via MHC class I whereas antigen ingested by receptor-mediated endocytosis is presented via MHC class II.
    Peppelenbosch MP; DeSmedt M; Pynaert G; van Deventer SJ; Grooten J
    J Immunol; 2000 Aug; 165(4):1984-91. PubMed ID: 10925281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen processing of two H2-IEd-restricted epitopes is differentially influenced by the structural changes in a viral glycoprotein.
    Chianese-Bullock KA; Russell HI; Moller C; Gerhard W; Monaco JJ; Eisenlohr LC
    J Immunol; 1998 Aug; 161(4):1599-607. PubMed ID: 9712021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of generation and persistence on membrane class II molecules of a viral peptide expressed on foreign and self proteins.
    Bot A; Bot S; Antohi S; Karjalainen K; Bona C
    J Immunol; 1996 Oct; 157(8):3436-42. PubMed ID: 8871642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Dendritic Cells Alters the Mechanism of MHC Class II Antigen Presentation to CD4 T Cells.
    Cho KJ; Ishido S; Eisenlohr LC; Roche PA
    J Immunol; 2020 Mar; 204(6):1621-1629. PubMed ID: 31996461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen.
    Pinet V; Malnati MS; Long EO
    J Immunol; 1994 May; 152(10):4852-60. PubMed ID: 8176208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of APC in the selection of immunodominant T cell epitopes.
    Ma C; Whiteley PE; Cameron PM; Freed DC; Pressey A; Chen SL; Garni-Wagner B; Fang C; Zaller DM; Wicker LS; Blum JS
    J Immunol; 1999 Dec; 163(12):6413-23. PubMed ID: 10586031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cysteinylation of MHC class II ligands: peptide endocytosis and reduction within APC influences T cell recognition.
    Haque MA; Hawes JW; Blum JS
    J Immunol; 2001 Apr; 166(7):4543-51. PubMed ID: 11254711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two T cell epitopes from the M5 protein of viable Streptococcus pyogenes engage different pathways of bacterial antigen processing in mouse macrophages.
    Delvig AA; Robinson JH
    J Immunol; 1998 Jun; 160(11):5267-72. PubMed ID: 9605123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presentation of endogenously synthesized MHC class II-restricted epitopes by MHC class II cancer vaccines is independent of transporter associated with Ag processing and the proteasome.
    Dissanayake SK; Tuera N; Ostrand-Rosenberg S
    J Immunol; 2005 Feb; 174(4):1811-9. PubMed ID: 15699107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class II MHC-restricted T cell determinants processed from either endosomes or the cytosol show similar requirements for host protein transport but different kinetics of presentation.
    Hackett CJ; Yewdell JW; Bennink JR; Wysocka M
    J Immunol; 1991 May; 146(9):2944-51. PubMed ID: 1673146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A major T cell determinant from the influenza virus hemagglutinin (HA) can be a cryptic self peptide in HA transgenic mice.
    Shih FF; Cerasoli DM; Caton AJ
    Int Immunol; 1997 Feb; 9(2):249-61. PubMed ID: 9040007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites.
    Rajnavölgyi E; Horváth A; Gogolák P; Tóth GK; Fazekas G; Fridkin M; Pecht I
    Eur J Immunol; 1997 Dec; 27(12):3105-14. PubMed ID: 9464794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system.
    Oxenius A; Bachmann MF; Ashton-Rickardt PG; Tonegawa S; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1995 Dec; 25(12):3402-11. PubMed ID: 8566030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor cells present MHC class II-restricted nuclear and mitochondrial antigens and are the predominant antigen presenting cells in vivo.
    Qi L; Rojas JM; Ostrand-Rosenberg S
    J Immunol; 2000 Nov; 165(10):5451-61. PubMed ID: 11067897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phagosomes acquire nascent and recycling class II MHC molecules but primarily use nascent molecules in phagocytic antigen processing.
    Ramachandra L; Harding CV
    J Immunol; 2000 May; 164(10):5103-12. PubMed ID: 10799867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting edge: editing of recycling class II:peptide complexes by HLA-DM.
    Pathak SS; Lich JD; Blum JS
    J Immunol; 2001 Jul; 167(2):632-5. PubMed ID: 11441064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunodominance does not result from peptide competition for MHC class II presentation.
    Lo-Man R; Langeveld JP; Martineau P; Hofnung M; Meloen RH; Leclerc C
    J Immunol; 1998 Feb; 160(4):1759-66. PubMed ID: 9469434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.